Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Yokota SJ, Facciponte JG, Kelleher RJ Jr, Shultz LD, Loyall JL, Parsons RR, Odunsi K, Frelinger JG, Lord EM, Gerber SA, Balu-Iyer SV, Bankert RB.

Cancer Immun. 2013 May 31;13:11. Print 2013.

2.

Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.

Bankert RB, Balu-Iyer SV, Odunsi K, Shultz LD, Kelleher RJ Jr, Barnas JL, Simpson-Abelson M, Parsons R, Yokota SJ.

PLoS One. 2011;6(9):e24420. doi: 10.1371/journal.pone.0024420. Epub 2011 Sep 15.

3.

T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.

Barnas JL, Simpson-Abelson MR, Yokota SJ, Kelleher RJ, Bankert RB.

Cancer Microenviron. 2010 Mar 31;3(1):29-47. doi: 10.1007/s12307-010-0044-5.

4.

IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments.

Simpson-Abelson MR, Purohit VS, Pang WM, Iyer V, Odunsi K, Demmy TL, Yokota SJ, Loyall JL, Kelleher RJ Jr, Balu-Iyer S, Bankert RB.

Clin Immunol. 2009 Jul;132(1):71-82. doi: 10.1016/j.clim.2009.03.516. Epub 2009 Apr 22.

5.

Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.

Simpson-Abelson MR, Sonnenberg GF, Takita H, Yokota SJ, Conway TF Jr, Kelleher RJ Jr, Shultz LD, Barcos M, Bankert RB.

J Immunol. 2008 May 15;180(10):7009-18.

6.

Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.

Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB.

J Immunol. 2007 May 1;178(9):5552-62.

7.

Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells.

Broderick L, Yokota SJ, Reineke J, Mathiowitz E, Stewart CC, Barcos M, Kelleher RJ Jr, Bankert RB.

J Immunol. 2005 Jan 15;174(2):898-906.

8.

The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients.

Abra RM, Bankert RB, Chen F, Egilmez NK, Huang K, Saville R, Slater JL, Sugano M, Yokota SJ.

J Liposome Res. 2002 Feb-May;12(1-2):1-3. Review.

PMID:
12604032
9.
10.

In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.

Egilmez NK, Cuenca R, Yokota SJ, Sorgi F, Bankert RB.

Gene Ther. 1996 Jul;3(7):607-14.

PMID:
8818648
11.
12.

The effect of free fatty acids on spectrin organization in lymphocytes.

Stephen FD, Yokota SJ, Repasky EA.

Cell Biophys. 1990 Dec;17(3):269-82.

PMID:
1714352

Supplemental Content

Loading ...
Support Center